Pediatr Allergy Respir Dis.  2009 Mar;19(1):20-27.

Usefulness of Percutaneous Oxygen Saturation Monitoring as a Predictor of Deterioration of Lung Function in Korean Children with Asthma

Affiliations
  • 1Department of Pediatrics, Inha University College of Medicine, Incheon, Korea. dhnlim@naver.com

Abstract

PURPOSE
Our study was designed to verify the correlation between the level of percutaneous arterial oxygen saturation (SpO2) and forced expiratory volume in 1 second (FEV1) and to classify the severity according to SpO2 level when asthma exacerbation is developed.
METHODS
We performed the methacholine bronchial provocation tests with monitoring SpO2 on 350 children who visited the pediatric allergy clinic with chronic cough or recurrent wheezing from August 2006 to August 2008.
RESULTS
There was a significant correlation between FEV1%fall and SpO2 (r=-0.814, P< 0.01). The mean value of SpO2 was 95.80%+/-1.2% when decrement of FEV1 was 20%. It was 92.3%+/-0.81% when FEV1 decreased by 40%.
CONCLUSION
Monitoring SpO2 is a convenient and reliable objective method to determine an appropriate therapeutic option when the pulmonary function test or arteial blood gas analysis is not available in children with asthma. We suggest less than 96% of SpO2 for the moderate attack, less than 92% for the severe attack, as the criteria for the severity of asthma exacerbations in Korea, which is higher than those suggested by GINA guideline or Japanese guidelines.

Keyword

Methacholine bronchial provocation test; Percutaneous arterial oxygen saturation; Forced expiratory volume in 1 second

MeSH Terms

Asian Continental Ancestry Group
Asthma
Blood Gas Analysis
Bronchial Provocation Tests
Child
Cough
Forced Expiratory Volume
Humans
Hypersensitivity
Korea
Lung
Methacholine Chloride
Oxygen
Respiratory Function Tests
Respiratory Sounds
Methacholine Chloride
Oxygen
Full Text Links
  • PARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr